Aureka Biotechnologies
PrivateLast Round
Series A
Extension
Apr 28, 2026
Total Funding Raised
$100M
Momentum Score
50 /100
Company Overview
Aureka Biotechnologies is a biotechnology company that develops a therapeutic discovery platform using generative AI and high-throughput screening to design and discover antibody therapeutics.
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aureka Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
Aureka Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 28, 2026 | ||||
| Series A | Nov 10, 2025 | ||||
| Seed | Mar 1, 2024 |
Aureka Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A Extension |
| HongShan | Series A Extension |
| 5Y Capital | Series A Extension, Series A |
| NRL Capital | Series A Extension, Series A, Seed |
| Qiming Venture Partners | Series A Extension, Series A |
| K2 Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Raised $35M led by HongShan (红杉中国)
- Jan 29, 2026
Monthly visitors increased 568% MoM.
Aureka Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aureka Biotechnologies's valuation, stock price, and market status.
